Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_assertion type Assertion NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_head.
- NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_assertion description "[Results showed that treatment of SKOV3 and OVCAR3 cells with CHK1 inhibitor PD 407824 led to sensitization of ovarian cancer cells to cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_provenance.
- NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_assertion evidence source_evidence_literature NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_provenance.
- NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_assertion SIO_000772 20722101 NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_provenance.
- NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_assertion wasDerivedFrom befree-2016 NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_provenance.
- NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_assertion wasGeneratedBy ECO_0000203 NP833707.RAjDe0GHi1W9E4fA4L9w0-ZXl4Kk8Dfm0Jf6gYPfCSjaU130_provenance.